Morgan Stanley : Increase of volatility
Entry price | Target | Stop-loss | Potential |
---|
$52.42 |
$63.9 |
$47.49 |
+21.9% |
---|
The return of higher trading volumes and volatility could reflect theoretically the starting point of the return of a new upward move for shares in Morgan Stanley. The upward movement can be expected to continue.
Strengths● The group's activity appears highly profitable thanks to its outperforming net margins.
● Considering the small differences between the analysts' various estimates, the group's business visibility is good.
● Historically, the company has been releasing figures that are above expectations.
● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● For the past twelve months, EPS forecast has been revised upwards.
● Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses● The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
● The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.